These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3404713)

  • 61. Pulmonary-renal syndromes in the intensive care unit.
    Rodriguez W; Hanania N; Guy E; Guntupalli J
    Crit Care Clin; 2002 Oct; 18(4):881-95, x. PubMed ID: 12418445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intensive plasma exchange in crescentic glomerulonephritis: help or no help?
    Glassock RJ
    Am J Kidney Dis; 1992 Sep; 20(3):270-5. PubMed ID: 1519608
    [No Abstract]   [Full Text] [Related]  

  • 63. [The Cutting-edge of Medicine; Rapidly progressive glomerulonephritis].
    Usui J; Yamagata K
    Nihon Naika Gakkai Zasshi; 2014 Oct; 103(10):2587-93. PubMed ID: 27514210
    [No Abstract]   [Full Text] [Related]  

  • 64. The treatment of immune glomerular disease.
    Williams DG
    Springer Semin Immunopathol; 1987; 9(4):417-29. PubMed ID: 2963398
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of oligoanuric anti-GBM nephritis.
    Walker RG; Becker GJ; d'Apice AJ; Kincaid-Smith P
    Lancet; 1986 Mar; 1(8479):508. PubMed ID: 2869249
    [No Abstract]   [Full Text] [Related]  

  • 66. Summaries for patients. Long-term outcome of patients with kidney damage due to Goodpasture disease wo receive very intensive treatment.
    Ann Intern Med; 2001 Jun; 134(11):S-10. PubMed ID: 11396431
    [No Abstract]   [Full Text] [Related]  

  • 67. What are the Newer Applications for Therapeutic Apheresis in Nephrology?: Current Indications for Therapeutic Plasma Exchange in Nephrology.
    Stevenson ME; Leung N; Winters JL
    Semin Dial; 2016 Sep; 29(5):350-3. PubMed ID: 27472247
    [No Abstract]   [Full Text] [Related]  

  • 68. Atypical presentation of anti-GBM nephritis in a 90-year-old patient.
    Okiro JO; Ebad CA; Khan AZ
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27899391
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasmapheresis in rapidly progressive glomerulonephritis.
    Smith PK; d'Apice JF
    Am J Med; 1978 Oct; 65(4):564-6. PubMed ID: 707515
    [No Abstract]   [Full Text] [Related]  

  • 70. [Chronic nephritic syndrome].
    Shibasaki T
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():15-9. PubMed ID: 15250261
    [No Abstract]   [Full Text] [Related]  

  • 71. [Immunotherapy of glomerulonephritis].
    Kurashige T; Wakiguchi H
    Nihon Rinsho; 1988 Jun; 46(6):1372-5. PubMed ID: 2458496
    [No Abstract]   [Full Text] [Related]  

  • 72. Quiz page. Fibrillary glomerulonephritis.
    Fogo AB
    Am J Kidney Dis; 2002 May; 39(5):liii. PubMed ID: 12038447
    [No Abstract]   [Full Text] [Related]  

  • 73. Anti-glomerular basement membrane antibody-mediated nephritis: when not to treat.
    Andrews PA
    Nephrol Dial Transplant; 1999 Apr; 14(4):1032-3. PubMed ID: 10328502
    [No Abstract]   [Full Text] [Related]  

  • 74. [Progress in treatment and diagnosis of renal diseases. I. Primary glomerular diseases. 2. Chronic glomerulonephritis].
    Nishi S; Arakawa M
    Nihon Naika Gakkai Zasshi; 1996 Oct; 85(10):1631-8. PubMed ID: 8999053
    [No Abstract]   [Full Text] [Related]  

  • 75. Plasma exchange--how does it work?
    Keller F; Schultze G; Offermann G; Molzahn M
    Int J Artif Organs; 1982 Jul; 5(4):230-1. PubMed ID: 7118285
    [No Abstract]   [Full Text] [Related]  

  • 76. Aggressive immunosuppression in glomerulonephritis.
    McClelland P; Williams PS; Stevens ME; Bone JM
    Nephrol Dial Transplant; 1989; 4(10):917-8. PubMed ID: 2515499
    [No Abstract]   [Full Text] [Related]  

  • 77. [Progress in diagnosis and treatment of glomerulopathies].
    Paczek L
    Pol Arch Med Wewn; 1997 Oct; 98(10):304-6. PubMed ID: 9557083
    [No Abstract]   [Full Text] [Related]  

  • 78. [Primary and secondary glomerular diseases].
    Birck R; Banas B
    Dtsch Med Wochenschr; 2012 Jun; 137(22):1179-82. PubMed ID: 22585537
    [No Abstract]   [Full Text] [Related]  

  • 79. Industry Trends: Antegren -- Novel drug for autoimmune diseases.
    Yang B; Wang JJ
    Discov Med; 2004 Feb; 4(20):13-4. PubMed ID: 20705009
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 5) Anti-GBM antibody diseases].
    Nagasawa T
    Nihon Rinsho; 1988 Apr; 46(4):918-24. PubMed ID: 3404713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.